chloroquine has been researched along with Corneal Opacity in 12 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Corneal Opacity: Disorder occurring in the central or peripheral area of the cornea. The usual degree of transparency becomes relatively opaque.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (91.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| THORP, RH | 1 |
| KAHAN, A | 1 |
| BENCZE, G | 1 |
| OLAH, M | 1 |
| LAKATOS, L | 1 |
| KERSLEY, GD | 1 |
| LLOYD, LA | 1 |
| HILTZ, JW | 1 |
| Slowik, C | 1 |
| Somodi, S | 1 |
| von Gruben, C | 1 |
| Richter, A | 1 |
| Guthoff, R | 1 |
| Tanaka, M | 1 |
| Kanai, A | 1 |
| Nakajima, A | 1 |
| Trojan, HJ | 1 |
| Thiel, HJ | 1 |
| Lal, S | 1 |
| Gupta, AK | 1 |
| Laaksonen, AL | 1 |
| Koskiahde, V | 1 |
| Juva, K | 1 |
| Godel, V | 1 |
| Nemet, P | 1 |
| Stein, R | 1 |
| Bertrand, JJ | 1 |
| Debeyre, N | 1 |
| Kahn, MF | 1 |
| Ryckewaert, A | 1 |
1 review available for chloroquine and Corneal Opacity
| Article | Year |
|---|---|
[Epithelium of the cornea and its significance for transparency].
Topics: Aerobiosis; Air; Chloroquine; Cornea; Corneal Dystrophies, Hereditary; Corneal Opacity; Edema; Epith | 1974 |
11 other studies available for chloroquine and Corneal Opacity
| Article | Year |
|---|---|
The pharmacology and toxicology of chloroquine.
Topics: Chloroquine; Corneal Opacity; Humans; Retina | 1961 |
[ON THE SIDE EFFECT OF CHLOROQUINE THERAPY IN RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS].
Topics: Arthritis; Arthritis, Rheumatoid; Chloroquine; Corneal Opacity; Gastroenterology; Lupus Erythematosu | 1964 |
THE VALUE AND DANGERS OF ANTIMALARIAL THERAPY IN ARTHRITIS WITH SPECIAL RELATION TO OPHTHALMIC COMPLICATIONS.
Topics: Antimalarials; Arthritis; Arthritis, Rheumatoid; Chloroquine; Corneal Opacity; Electroretinography; | 1964 |
OCULAR COMPLICATIONS OF CHLOROQUINE THERAPY.
Topics: Arthritis, Rheumatoid; Blindness; Chloroquine; Collagen Diseases; Cornea; Corneal Opacity; Drug Ther | 1965 |
[Detection of morphological corneal changes caused by chloroquine therapy using confocal in vivo microscopy].
Topics: Adult; Aged; Chloroquine; Cornea; Corneal Opacity; Dose-Response Relationship, Drug; Drug Administra | 1997 |
[Electron-microscopic studies on pathologic corneal epithelium. Part 2: Chloroquine keratopathy (author's transl].
Topics: Adult; Chloroquine; Cornea; Corneal Opacity; Epithelium; Female; Humans; Microscopy, Electron | 1978 |
[Eye complications in the long-term treatment with chloroquin. Study carried out in Togo].
Topics: Cataract; Chloroquine; Corneal Opacity; Eye Diseases; Female; Humans; Macular Degeneration; Malaria; | 1975 |
Lenticular deposits associated with chloroquine Keratopathy.
Topics: Cataract; Chloroquine; Corneal Opacity; Humans; Leprosy; Male; Middle Aged | 1974 |
[Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis].
Topics: Administration, Oral; Adolescent; Arthritis, Juvenile; Child; Child, Preschool; Chloroquine; Corneal | 1974 |
[Ocular involvement in chloroquine therapy].
Topics: Adult; Angiography; Chloroquine; Corneal Opacity; Dark Adaptation; Electroretinography; Eye Diseases | 1972 |
[Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
Topics: Antimalarials; Chloroquine; Corneal Opacity; Drug Tolerance; Electroretinography; Eye Diseases; Hydr | 1968 |